New diagnostic technique picks up the S in vision

May 1, 2018, University of Bradford
Credit: CC0 Public Domain

A new technique that could help improve diagnosis of vision disorders has been successfully tested at the University of Bradford, UK.

The researchers showed the technique can isolate responses from the different retinal cells that we use to see, including those that are most vulnerable to damage and disease, known as S-cone photoreceptors.

Diseases that affect S-cones include Types 1 and 2 diabetes, glaucoma and and some rare genetic disorders, such as enhanced S-cone syndrome and blue cone monochromatism.

S-cone photoreceptors respond to light of short wavelengths and help us see the blue part of the colour spectrum. However, it is difficult to test their function independently of the other types of photoreceptor in the eye: L-cone (long wavelength covering the red spectrum), M-cone (medium wave-length covering the yellow and green spectrum) and rod photoreceptors, that help us see when light levels are low.

Study lead, Dr Declan McKeefry, from the University of Bradford's School of Optometry conducts clinical diagnostics of for the NHS. He says: "Diagnosis of some eye diseases can be difficult as they have similar symptoms, such as blurred or distorted vision and inability to see colour, and often a variety of genetic causes. Understanding exactly which cells are affected in the eye can be the key piece of the jigsaw that enables an accurate diagnosis, but until now, it's been almost impossible to test the function of the S-cones separately."

The standard method of diagnosis involves flashing lights at the eye, and measuring the response using an electroretinogram (ERG) - similar to an ECG used to measure heart activity. But because this picks up responses from all the retinal photoreceptors, it can mask certain diseases where S-cones are disproportionately affected.

Dr McKeefry used stimuli at different wavelengths to 'silence' the L- and M-cones and the rods so only the signals from the S-cones are picked up. The technique is the first to silence these three together and so is known as 'triple silent substitution'.

He tested the technique on 16 volunteers with normal colour vision, two patients previously diagnosed with blue cone monochromatism (BCM) and one patient who has enhanced S-cone syndrome (ESCS).

BCM is a genetic disorder where the L- and M-cones don't function at all, leading to impaired colour vision. In ESCS, there are higher numbers of S-cones in the retina which are hyper-sensitive, crowding out the L- and M-cones.

Dr McKeefry's tests showed exactly the results that would be expected from these three types of volunteers - normal signals from all three cones in the healthy volunteers, no response from L- and M-cones in the BCM patients and an overactive response from the S-cones in the ESCS patient. Together, this showed that the responses from the S-cones were being picked up independently of the other cells, proving the technique could be used confidently for assessing S-cone activity or damage.

Dr McKeefry says: "Because we know that there are no active L- and M-cones in BCM patients, this shows that our technique is effectively isolating the right photoreceptors, as we only got signals from the S-cones. This means we could use the to spot damage in the S-cones or an altered pattern, as in ESCS, which could help in diagnosis of this condition."

While currently there are no treatments for BCM or ESCS, recent medical advances do hold out hope, as Dr McKeefry explains: "Stem cell therapy has been shown to help restore eye function so this is a route that holds potential for these . But for that kind of therapy to work, it's even more important to know which cells are affected by the disease, and triple silent substitution can help us to do that much more accurately."

The research is published in the current issue of the Journal of the Optical Society of America.

Explore further: New hope against disease that brings a colorless world

More information: J. Maguire et al, Human S-cone electroretinograms obtained by silent substitution stimulation, Journal of the Optical Society of America A (2018). DOI: 10.1364/JOSAA.35.000B11

Related Stories

New hope against disease that brings a colorless world

April 6, 2018
(HealthDay)—Imagine a world in black and white.

Rods in the retina contribute to daylight vision

November 27, 2017
An international research team headed by Thomas Münch from Tübingen University found the contribution of rod photoreceptors in mouse retinas to be much greater than previously assumed. Rods cannot distinguish between colours ...

Zebrafish may hold the answer to repairing damaged retinas and returning eyesight to people

January 31, 2013
Zebrafish, the staple of genetic research, may hold the answer to repairing damaged retinas and returning eye-sight to people.

Scientists unravel the cause of rare genetic disease: Goldman-Favre Syndrome explained

August 31, 2011
A new research report published in The FASEB Journal will help ophthalmologists and scientists better understand a rare genetic disease that causes increased susceptibility to blue light, night blindness, and decreased vision ...

Midnight Blue—A new system for color vision

April 14, 2016
The swirling skies of Vincent Van Gogh's Starry Night illustrate a mystery that has eluded biologists for more than a century—why do we perceive the color blue in the dimly lit night sky? A newly discovered mechanism of ...

Recommended for you

Outbreak of preventable eye infection in contact lens wearers

September 21, 2018
A new outbreak of a rare but preventable eye infection that can cause blindness, has been identified in contact lens wearers in a new study led by UCL and Moorfields Eye Hospital researchers.

Newly formed blood vessels may contribute to eye disease

September 14, 2018
Newly formed blood vessels may be cracks in the barrier between the bloodstream and the eye, according to a Northwestern Medicine study published in the Proceedings of the National Academy of Sciences.

Eye disease can cause blindness, and it's on the rise

August 29, 2018
A new study into recent cases of ocular syphilis warns increasing numbers of people are at risk of permanent damage to their vision.

INSiGHT identifies unique retinal regulatory genes

August 28, 2018
Vision begins in the retina, a light-sensing neural network in the eye that is critical for our ability observe the world around us. Researches at Baylor College of Medicine, Texas Children's Hospital and the Hospital for ...

Alzheimer's one day may be predicted during eye exam

August 23, 2018
It may be possible in the future to screen patients for Alzheimer's disease using an eye exam.

Researchers find potential new gene therapy for blinding disease

August 20, 2018
The last year has seen milestones in the gene therapy field, with FDA approvals to treat cancer and an inherited blinding disorder. New findings from a team led by University of Pennsylvania vision scientists, who have in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.